淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4686人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1998048, encodeId=e1f319980480b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Oncol：Zanubrutinib vs 苯达莫司汀-利妥昔单抗治疗初治慢性淋巴细胞白血病和小淋巴细胞淋巴瘤, objectType=article, longId=731945, objectId=fdbde3194517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdbde3194517, replyNumber=0, likeNumber=70, createdTime=2023-05-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdbde3194517, moduleTitle=Lancet Oncol：Zanubrutinib vs 苯达莫司汀-利妥昔单抗治疗初治慢性淋巴细胞白血病和小淋巴细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdbde3194517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998020, encodeId=8b8d199802073, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！, objectType=article, longId=217212, objectId=a44c21e21243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a44c21e21243, replyNumber=0, likeNumber=74, createdTime=2021-12-24, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a44c21e21243, moduleTitle=Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a44c21e21243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998033, encodeId=21b7199803367, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leuk Res：高 Bax/Bcl-2 比值与 B 细胞慢性淋巴细胞白血病患者的良好预后和更好的生存率相关, objectType=article, longId=293668, objectId=78f02936684d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f02936684d, replyNumber=0, likeNumber=78, createdTime=2022-01-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f02936684d, moduleTitle=Leuk Res：高 Bax/Bcl-2 比值与 B 细胞慢性淋巴细胞白血病患者的良好预后和更好的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78f02936684d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998034, encodeId=f6f91998034c1, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=FDA叫停Ukoniq治疗慢性淋巴细胞白血病的临床试验, objectType=article, longId=295115, objectId=db3f29511518, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db3f29511518, replyNumber=0, likeNumber=148, createdTime=2022-11-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db3f29511518, moduleTitle=FDA叫停Ukoniq治疗慢性淋巴细胞白血病的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db3f29511518)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998042, encodeId=d4d11998042cd, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【即将直播】慢性淋巴细胞白血病诊疗3天训练营|Day 1：慢性淋巴细胞白血病的诊断与评估, objectType=article, longId=728217, objectId=3f0de282176e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0de282176e, replyNumber=0, likeNumber=83, createdTime=2022-06-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0de282176e, moduleTitle=【即将直播】慢性淋巴细胞白血病诊疗3天训练营|Day 1：慢性淋巴细胞白血病的诊断与评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f0de282176e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998029, encodeId=d52d1998029ad, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=中国医学科学院血液病医院王迎直播解读：成人Ph+急性淋巴细胞白血病的治疗, objectType=article, longId=219231, objectId=b322219231d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b322219231d9, replyNumber=0, likeNumber=45, createdTime=2022-02-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b322219231d9, moduleTitle=中国医学科学院血液病医院王迎直播解读：成人Ph+急性淋巴细胞白血病的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b322219231d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998043, encodeId=2d90199804351, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物 , objectType=article, longId=728558, objectId=0b3be2855881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3be2855881, replyNumber=0, likeNumber=59, createdTime=2023-02-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3be2855881, moduleTitle=Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3be2855881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998019, encodeId=06981998019c7, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leukemia：急性淋巴细胞白血病的内皮功能障碍和血栓栓塞相关生物标志物鉴定, objectType=article, longId=216773, objectId=285d216e73b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=285d216e73b0, replyNumber=0, likeNumber=140, createdTime=2022-08-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=285d216e73b0, moduleTitle=Leukemia：急性淋巴细胞白血病的内皮功能障碍和血栓栓塞相关生物标志物鉴定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=285d216e73b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998021, encodeId=dd091998021c2, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nature Communications：脂肪细胞破坏急性淋巴细胞白血病的转化程序，有利于肿瘤的存活和持久性, objectType=article, longId=217372, objectId=c8ba21e372af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ba21e372af, replyNumber=0, likeNumber=79, createdTime=2022-05-22, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ba21e372af, moduleTitle=Nature Communications：脂肪细胞破坏急性淋巴细胞白血病的转化程序，有利于肿瘤的存活和持久性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ba21e372af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998035, encodeId=22f3199803507, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：奥比妥珠单抗+依鲁替尼+维奈托克一线治疗高风险的慢性淋巴细胞白血病, objectType=article, longId=300815, objectId=6c63300815c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c63300815c7, replyNumber=0, likeNumber=99, createdTime=2023-02-05, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c63300815c7, moduleTitle=Blood：奥比妥珠单抗+依鲁替尼+维奈托克一线治疗高风险的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c63300815c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998036, encodeId=709d1998036b7, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Haematol：甲氨蝶呤相关中枢神经毒性：急性淋巴细胞白血病治疗儿童的临床特征、危险因素和全基因组关联研究, objectType=article, longId=301765, objectId=2c41301e651f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c41301e651f, replyNumber=0, likeNumber=152, createdTime=2022-05-16, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c41301e651f, moduleTitle=Haematol：甲氨蝶呤相关中枢神经毒性：急性淋巴细胞白血病治疗儿童的临床特征、危险因素和全基因组关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c41301e651f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998037, encodeId=5d69199803e71, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=BJH：慢性淋巴细胞白血病对黑色素瘤结局的影响：一项回顾性病例对照研究, objectType=article, longId=302063, objectId=7e953020633b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e953020633b, replyNumber=0, likeNumber=110, createdTime=2022-07-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e953020633b, moduleTitle=BJH：慢性淋巴细胞白血病对黑色素瘤结局的影响：一项回顾性病例对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e953020633b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998030, encodeId=4b461998030d5, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Clin Lymphoma Myeloma Leuk：急性淋巴细胞白血病单倍体移植和其他移植物来源的临床结果比较, objectType=article, longId=221520, objectId=f33a221520fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f33a221520fb, replyNumber=0, likeNumber=79, createdTime=2022-08-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f33a221520fb, moduleTitle=Clin Lymphoma Myeloma Leuk：急性淋巴细胞白血病单倍体移植和其他移植物来源的临床结果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f33a221520fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998031, encodeId=476b1998031f4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=一例迟来的Ph阳性急性淋巴细胞白血病的诊断, objectType=article, longId=292552, objectId=61c0292552d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c0292552d9, replyNumber=0, likeNumber=87, createdTime=2022-08-06, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c0292552d9, moduleTitle=一例迟来的Ph阳性急性淋巴细胞白血病的诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c0292552d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998032, encodeId=95991998032e5, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=急性T淋巴细胞白血病伴髓系表达orMPAL双表型？, objectType=article, longId=292741, objectId=3c27292e41e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c27292e41e5, replyNumber=0, likeNumber=65, createdTime=2022-11-19, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c27292e41e5, moduleTitle=急性T淋巴细胞白血病伴髓系表达orMPAL双表型？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c27292e41e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998027, encodeId=b714199802e3c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=治疗慢性淋巴细胞白血病，双特异性γδ T细胞结合抗体LAVA-051获得FDA孤儿药认证, objectType=article, longId=218735, objectId=059d218e355d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=059d218e355d, replyNumber=0, likeNumber=66, createdTime=2022-06-06, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=059d218e355d, moduleTitle=治疗慢性淋巴细胞白血病，双特异性γδ T细胞结合抗体LAVA-051获得FDA孤儿药认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=059d218e355d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998025, encodeId=1e7819980259d, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=J Clin Oncol：依鲁替尼联合维奈托克作为慢性淋巴细胞白血病一线治疗的良好预后, objectType=article, longId=218366, objectId=42d22183667a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42d22183667a, replyNumber=0, likeNumber=70, createdTime=2021-12-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42d22183667a, moduleTitle=J Clin Oncol：依鲁替尼联合维奈托克作为慢性淋巴细胞白血病一线治疗的良好预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42d22183667a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998015, encodeId=aae719980157f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nat Commun：靶向PI3K/AKT的过度激活诱导慢性淋巴细胞白血病的细胞死亡, objectType=article, longId=212706, objectId=7958212e06d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7958212e06d6, replyNumber=0, likeNumber=89, createdTime=2021-10-31, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7958212e06d6, moduleTitle=Nat Commun：靶向PI3K/AKT的过度激活诱导慢性淋巴细胞白血病的细胞死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7958212e06d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998016, encodeId=67551998016d7, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发, objectType=article, longId=214726, objectId=0cd1214e26c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cd1214e26c8, replyNumber=0, likeNumber=164, createdTime=2022-05-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cd1214e26c8, moduleTitle=Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cd1214e26c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998018, encodeId=ec7c1998018be, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leukemia：CXCR4的过度激活驱动慢性淋巴细胞白血病的发生发展, objectType=article, longId=215571, objectId=44ee2155e156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44ee2155e156, replyNumber=0, likeNumber=113, createdTime=2022-06-20, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44ee2155e156, moduleTitle=Leukemia：CXCR4的过度激活驱动慢性淋巴细胞白血病的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44ee2155e156)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Oncol：Zanubrutinib vs 苯达莫司汀-利妥昔单抗治疗初治慢性淋巴细胞白血病和小淋巴细胞淋巴瘤

2023-05-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！

2021-12-24

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leuk Res：高 Bax/Bcl-2 比值与 B 细胞慢性淋巴细胞白血病患者的良好预后和更好的生存率相关

2022-01-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

FDA叫停Ukoniq治疗慢性淋巴细胞白血病的临床试验

2022-11-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【即将直播】慢性淋巴细胞白血病诊疗3天训练营|Day 1：慢性淋巴细胞白血病的诊断与评估

2022-06-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

中国医学科学院血液病医院王迎直播解读：成人Ph+急性淋巴细胞白血病的治疗

2022-02-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物

2023-02-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leukemia：急性淋巴细胞白血病的内皮功能障碍和血栓栓塞相关生物标志物鉴定

2022-08-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nature Communications：脂肪细胞破坏急性淋巴细胞白血病的转化程序，有利于肿瘤的存活和持久性

2022-05-22

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：奥比妥珠单抗+依鲁替尼+维奈托克一线治疗高风险的慢性淋巴细胞白血病

2023-02-05

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Haematol：甲氨蝶呤相关中枢神经毒性：急性淋巴细胞白血病治疗儿童的临床特征、危险因素和全基因组关联研究

2022-05-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

BJH：慢性淋巴细胞白血病对黑色素瘤结局的影响：一项回顾性病例对照研究

2022-07-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Clin Lymphoma Myeloma Leuk：急性淋巴细胞白血病单倍体移植和其他移植物来源的临床结果比较

2022-08-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

一例迟来的Ph阳性急性淋巴细胞白血病的诊断

2022-08-06

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

急性T淋巴细胞白血病伴髓系表达orMPAL双表型？

2022-11-19

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

治疗慢性淋巴细胞白血病，双特异性γδ T细胞结合抗体LAVA-051获得FDA孤儿药认证

2022-06-06

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

J Clin Oncol：依鲁替尼联合维奈托克作为慢性淋巴细胞白血病一线治疗的良好预后

2021-12-01

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nat Commun：靶向PI3K/AKT的过度激活诱导慢性淋巴细胞白血病的细胞死亡

2021-10-31

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发

2022-05-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leukemia：CXCR4的过度激活驱动慢性淋巴细胞白血病的发生发展

2022-06-20

科室
- - 订阅+
  - 更多科室
工具
服务